• 40001百老汇(中国)集团公司-百老汇(电子游戏)官网40001百老汇电子

    Privacy settings

    This website may store cookies on your browser. Cookies are mostly used to make the website work as you expect it to. No cookie will directly identify you, but it can give you a more personalized browsing experience.

    Endovastec respects your privacy rights, so you can block some types of cookies.  Technically non-essential cookies and tracking mechanisms, that enable us to provide you with customized offers (marketing cookies), are only used if you have given prior consent to such use.

    Strictly necessary cookies
    Consent to marketing cookies

    By clicking "Save", only the cookies you selected will be used. You can with draw the consent that you granted here at any time by going to Cookies Settings. For more information, please see our Cookie Policy.

    Stock Code

    688016.SH

    Genyong Qiu
    Vice President and Secretary of the Board of Directors of Endovastec™

    Mr. Qiu Genyong, born in 1977, is a Chinese national with no permanent residency abroad and holds a master’s degree in Laws from Renmin University of China. He successively served as legal manager and legal director of the Legal Department and of Haier Group from August 1998 to March 2008; manager of the Legal Department of Zhejiang ReneSola Ltd. from April 2008 to July 2009; successively as legal director, senior director and executive director of WuXi AppTec (Shanghai) Co., Ltd. from July 2009 to November 2014; secretary of the Board of Directors of Shanghai SynTheAll Pharmaceutical Co., Ltd. from November 2014 to March 2019; and executive director of the Legal Department of Shanghai SynTheAll Pharmaceutical Co., Ltd. from April 2019 to April 2022. Currently, Mr. Qiu serves as vice president and secretary of the Board of Directors of Endovastec™.

    Mr. Qiu Genyong, born in 1977, is a Chinese national with no permanent residency abroad and holds a master’s degree in Laws from Renmin University of China. He successively served as legal manager and legal director of the Legal Department and of Haier Group from August 1998 to March 2008; manager of the Legal Department of Zhejiang ReneSola Ltd. from April 2008 to July 2009; successively as legal director, senior director and executive director of WuXi AppTec (Shanghai) Co., Ltd. from July 2009 to November 2014; secretary of the Board of Directors of Shanghai SynTheAll Pharmaceutical Co., Ltd. from November 2014 to March 2019; and executive director of the Legal Department of Shanghai SynTheAll Pharmaceutical Co., Ltd. from April 2019 to April 2022. Currently, Mr. Qiu serves as vice president and secretary of the Board of Directors of Endovastec™.

    40001百老汇电子